In severe cases, injecting drug mixtures containing xylazine can lead to rotting tissue, necessitating amputations. Public health officials have raised alarms about the spread of this “zombie drug” and its devastating impact on communities.
Geographical Spread and Concerns
While xylazine has been most prevalent in California and on the East Coast of the United States, recent evidence confirms its presence in Tijuana, Mexico. The influx and use on the U.S.-Mexico border, poses health risks for people in this region.
There has also been an increase in the drug’s presence in Australia, the UK and Europe.
This discovery raises concerns about the potential spread of xylazine into Southern California and other parts of the U.S.
The high prevalence of lidocaine in Tijuana’s illicit fentanyl supply may interfere with test strip accuracy regarding xylazine, complicating detection and intervention efforts.
Addressing the Threat
The decline in fentanyl-related deaths offers a glimmer of hope in the battle against opioid overdoses. However, the emergence and spread of xylazine, with its severe health implications, present a new and formidable challenge.
